Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells
- PMID: 217544
- DOI: 10.1016/0092-8674(79)90185-5
Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells
Abstract
A rabbit antiserum has been prepared against the B95-8 transforming strain of EBV. The antiserum has a high virus neutralizing titer (approximately 1:1000) against both the marmoset B95-8 EBV and the human P3HR-1 EBV. The neutralizing antibodies may be absorbed completely with EBV producer cell lines, but not with nonproducer cell lines or producer cell lines treated with phosphonoacetic acid (PAA) so as to be nonproducer. After repeated absorption with PAA-treated B95-8, the serum remains reactive with the membranes of producer cell lines as judged by immunofluorescence or the 125I--Staphylococcal protein A radioimmunoassay. Thus the neutralizing antigens are expressed on the membranes of producer cell lines and may be purified from this source using the serum and 125I--Staph A binding as an assay. The ability of the serum to differentiate between producer and nonproducer cells by means of cell surface determinants has been exploited to achieve a separation of these two populations from the same culture. Immunoprecipitation by the protein A technique shows that the serum recognizes two polypeptides from producer cells of approximate molecular weights 150,000 and 75,000.
Similar articles
-
Polypeptides of the Epstein-Barr virus membrane antigen complex.J Virol. 1979 Nov;32(2):458-67. doi: 10.1128/JVI.32.2.458-467.1979. J Virol. 1979. PMID: 228070 Free PMC article.
-
Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.Proc Natl Acad Sci U S A. 1980 May;77(5):2979-83. doi: 10.1073/pnas.77.5.2979. Proc Natl Acad Sci U S A. 1980. PMID: 6248876 Free PMC article.
-
Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.J Virol. 1981 Jul;39(1):172-84. doi: 10.1128/JVI.39.1.172-184.1981. J Virol. 1981. PMID: 6268807 Free PMC article.
-
Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.Proc Natl Acad Sci U S A. 1982 Jan;79(2):616-20. doi: 10.1073/pnas.79.2.616. Proc Natl Acad Sci U S A. 1982. PMID: 6176998 Free PMC article.
-
Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.J Virol. 1988 Aug;62(8):2614-21. doi: 10.1128/JVI.62.8.2614-2621.1988. J Virol. 1988. PMID: 2839689 Free PMC article.
Cited by
-
Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.J Exp Med. 1985 May 1;161(5):1097-111. doi: 10.1084/jem.161.5.1097. J Exp Med. 1985. PMID: 2580934 Free PMC article.
-
Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.Proc Natl Acad Sci U S A. 1982 Dec;79(23):7504-8. doi: 10.1073/pnas.79.23.7504. Proc Natl Acad Sci U S A. 1982. PMID: 6296836 Free PMC article.
-
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.J Clin Invest. 1982 Nov;70(5):1081-91. doi: 10.1172/jci110696. J Clin Invest. 1982. PMID: 6290536 Free PMC article.
-
Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.J Virol. 1983 May;46(2):547-56. doi: 10.1128/JVI.46.2.547-556.1983. J Virol. 1983. PMID: 6302318 Free PMC article.
-
Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.J Virol. 1987 Jun;61(6):1796-807. doi: 10.1128/JVI.61.6.1796-1807.1987. J Virol. 1987. PMID: 3033311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources